Jared W Klein
Overview
Explore the profile of Jared W Klein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
290
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie S, Spice C, Wedgeworth P, Langevin R, Lybarger K, Singh A, et al.
J Am Med Inform Assoc
. 2025 Mar;
PMID: 40085013
Objective: Artificial Intelligence (AI)-based approaches for extracting Social Drivers of Health (SDoH) from clinical notes offer healthcare systems an efficient way to identify patients' social needs, yet we know little...
2.
Tsui J, Stephens D, Collins B, Denisiuk E, Hallgren K, Blalock K, et al.
J Addict Med
. 2023 Aug;
17(4):491-492.
PMID: 37579119
No abstract available.
3.
DOnofrio G, Edelman E, Hawk K, Chawarski M, Pantalon M, Owens P, et al.
JAMA Netw Open
. 2023 Apr;
6(4):e235439.
PMID: 37017967
Importance: Emergency department (ED)-initiated buprenorphine for the treatment of opioid use disorder (OUD) is underused. Objective: To evaluate whether provision of ED-initiated buprenorphine with referral for OUD increased after implementation...
4.
Jack H, Denisiuk E, Collins B, Stephens D, Blalock K, Klein J, et al.
Subst Abus
. 2022 Jul;
43(1):1308-1316.
PMID: 35896006
: People with opioid use disorder (OUD) are increasingly started on buprenorphine in the hospital, yet many patients do not attend outpatient buprenorphine care after discharge. Peer providers, people in...
5.
Bhatraju E, Klein J, Hall A, Chen D, Iles-Shih M, Tsui J, et al.
J Addict Med
. 2021 Dec;
16(4):461-465.
PMID: 34954743
Objective: To describe the outcomes of buprenorphine/naloxone low dose induction with overlap of full opioid agonists among hospitalized patients with opioid use disorder (OUD) as an alternative to standard induction...
6.
Tsui J, Leroux B, Radick A, Schramm Z, Blalock K, LaBelle C, et al.
Drug Alcohol Depend
. 2021 Aug;
227:108917.
PMID: 34399136
Background: We conducted a pilot study to assess feasibility of using video directly-observed therapy (DOT) for patients initiating buprenorphine to evaluate whether it is associated with better opioid use disorder...
7.
James J, Marolf M, Klein J, Blalock K, Merrill J, Tsui J
Subst Use Misuse
. 2021 Jul;
56(11):1569-1575.
PMID: 34282999
Purpose: Improving access to buprenorphine treatment is necessary to address the national opioid use disorder (OUD) crisis. This study investigates attitudes about buprenorphine prescribing among staff at a primary care...
8.
Beieler A, Klein J, Bhatraju E, Iles-Shih M, Enzian L, Dhanireddy S
Open Forum Infect Dis
. 2021 Jun;
8(6):ofab285.
PMID: 34189180
Hospitalizations for serious infections in patients with opioid use disorder (OUD) experiencing homelessness are common. Patients receiving 4 interventions (infectious disease consultation, addiction consultation, case management, and medications for OUD...
9.
Chen J, Cabudol M, Williams E, Merrill J, Tsui J, Klein J
J Subst Abuse Treat
. 2021 Jun;
126:108463.
PMID: 34116814
Objectives: Office-based opioid treatment (OBOT) with buprenorphine is increasingly integrated in primary care to treat opioid use disorder (OUD). Online portals seek to engage patients in care of their chronic...
10.
Logan A, Jack H, Darnton J, Klein J
Subst Abus
. 2021 Apr;
42(4):944-950.
PMID: 33797320
The opioid use disorder (OUD) epidemic is a national public health crisis. Access to effective treatment with buprenorphine is limited, in part because few physicians are trained to prescribe it....